NA
DGX icon

Networth Advisors’s Quest Diagnostics DGX Stock Holding History

Networth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Hold
491
– – 0.06% 76
2026
Q1 		$96.2K Hold
491
– – 0.07% 72
2025
Q4 		$85.2K Buy
+491
New +$89.4K 0.06% 71

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Networth Advisors's DGX Position: Q2 2026 in Review

Networth Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 491 shares worth $104K. The position accounts for 0.06% of the portfolio, ranked #76.

Networth Advisors first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 577 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Networth Advisors held 491 shares of Quest Diagnostics worth $104K as of Q2 2026.
  • Networth Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.06% of Networth Advisors's portfolio in Q2 2026, its #76 holding.
  • Networth Advisors first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 577 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Networth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.